186 related articles for article (PubMed ID: 11682488)
1. Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells.
Wagner TC; Velichko S; Vogel D; Rani MR; Leung S; Ransohoff RM; Stark GR; Perez HD; Croze E
J Biol Chem; 2002 Jan; 277(2):1493-9. PubMed ID: 11682488
[TBL] [Abstract][Full Text] [Related]
2. Role of the intracellular domain of the human type I interferon receptor 2 chain (IFNAR2c) in interferon signaling. Expression of IFNAR2c truncation mutants in U5A cells.
Russell-Harde D; Wagner TC; Rani MR; Vogel D; Colamonici O; Ransohoff RM; Majchrzak B; Fish E; Perez HD; Croze E
J Biol Chem; 2000 Aug; 275(31):23981-5. PubMed ID: 10825167
[TBL] [Abstract][Full Text] [Related]
3. STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues.
Velichko S; Wagner TC; Turkson J; Jove R; Croze E
J Biol Chem; 2002 Sep; 277(38):35635-41. PubMed ID: 12105218
[TBL] [Abstract][Full Text] [Related]
4. The proximal tyrosines of the cytoplasmic domain of the beta chain of the type I interferon receptor are essential for signal transducer and activator of transcription (Stat) 2 activation. Evidence that two Stat2 sites are required to reach a threshold of interferon alpha-induced Stat2 tyrosine phosphorylation that allows normal formation of interferon-stimulated gene factor 3.
Nadeau OW; Domanski P; Usacheva A; Uddin S; Platanias LC; Pitha P; Raz R; Levy D; Majchrzak B; Fish E; Colamonici OR
J Biol Chem; 1999 Feb; 274(7):4045-52. PubMed ID: 9933596
[TBL] [Abstract][Full Text] [Related]
5. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.
Li X; Leung S; Kerr IM; Stark GR
Mol Cell Biol; 1997 Apr; 17(4):2048-56. PubMed ID: 9121453
[TBL] [Abstract][Full Text] [Related]
6. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
7. Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling.
Nguyen VP; Saleh AZ; Arch AE; Yan H; Piazza F; Kim J; Krolewski JJ
J Biol Chem; 2002 Mar; 277(12):9713-21. PubMed ID: 11786546
[TBL] [Abstract][Full Text] [Related]
8. Role of metazoan mediator proteins in interferon-responsive transcription.
Lau JF; Nusinzon I; Burakov D; Freedman LP; Horvath CM
Mol Cell Biol; 2003 Jan; 23(2):620-8. PubMed ID: 12509459
[TBL] [Abstract][Full Text] [Related]
9. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane signaling by the alpha subunit of the type I interferon receptor is essential for activation of the JAK kinases and the transcriptional factor ISGF3.
Colamonici OR; Platanias LC; Domanski P; Handa R; Gilmour KC; Diaz MO; Reich N; Pitha-Rowe P
J Biol Chem; 1995 Apr; 270(14):8188-93. PubMed ID: 7713924
[TBL] [Abstract][Full Text] [Related]
11. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
[TBL] [Abstract][Full Text] [Related]
12. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
13. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
[TBL] [Abstract][Full Text] [Related]
14. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC
J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3.
Bandyopadhyay SK; Leonard GT; Bandyopadhyay T; Stark GR; Sen GC
J Biol Chem; 1995 Aug; 270(33):19624-9. PubMed ID: 7642650
[TBL] [Abstract][Full Text] [Related]
16. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
[TBL] [Abstract][Full Text] [Related]
18. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
[TBL] [Abstract][Full Text] [Related]
19. Role of STAT2 in the alpha interferon signaling pathway.
Leung S; Qureshi SA; Kerr IM; Darnell JE; Stark GR
Mol Cell Biol; 1995 Mar; 15(3):1312-7. PubMed ID: 7532278
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
